# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Retail investors prepare for the first busy week in the Q3 earnings season, with Tesla, Netflix and Intel on deck.
HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ: VKTX) with a Buy and maintains $102...
BTIG analyst Justin Zelin reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $125 price target.
https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingre...
Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKT...
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...